Last reviewed · How we verify

Blood clot and simple suture — Competitive Intelligence Brief

Blood clot and simple suture (Blood clot and simple suture) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Area: Surgery/Wound Healing.

phase 3 Surgery/Wound Healing Small molecule Live · refreshed every 30 min

Target snapshot

Blood clot and simple suture (Blood clot and simple suture) — Fundación Eduardo Anitua. This is a biological hemostatic product that combines blood clotting factors with a suture material to promote wound healing and hemostasis.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Blood clot and simple suture TARGET Blood clot and simple suture Fundación Eduardo Anitua phase 3

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Blood clot and simple suture — Competitive Intelligence Brief. https://druglandscape.com/ci/blood-clot-and-simple-suture. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: